Navigation Links
Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008
Date:9/5/2008

Expert Pathologists Discuss the Latest Developments in Molecular Testing and Personalized Medicine

NORTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ -- The practice of pathology is at a transformation point. Molecular testing and the promise of personalized medicine will change the way patients are treated. Digital slides and other imaging technologies will change the way pathologists work. The College of American Pathologists is taking a leadership role in making sure that its members are ready for the future as central members of the patient care team. These topics as well as the latest on testing and diagnosing cancer will be the focus of the College's annual meeting, CAP '08 - The Pathologists' Meeting(TM). The meeting will be held on Sept. 25 - 28, 2008, at the Manchester Grand Hyatt San Diego.

At CAP '08, expert pathologists from around the globe will lead education seminars that provide practical tools, which can be incorporated immediately into pathology practices. Hot topics include genetic testing and the impact of increased requests for clinical consultations stemming from those tests; the current and future uses of telepathology to increase the quality and efficiency of pathology services; and the changing role of pathologists on the patient care team. An entire curriculum will focus on a comprehensive approach to gastrointestinal pathology. Courses will also examine the most recent testing guidelines for the human papillomavirus (HPV), the leading cause of cervical cancer.

"We've created an outstanding meeting, that will emphasize new technologies and techniques that will transform the specialty of pathology over the next five to 10 years and will positively impact the delivery of quality patient care," said CAP President Jared N. Schwartz, MD, PhD, FCAP. "Pathologists who attend will also learn about the most current developments in testing and diagnosis of a wide spectrum of malignancies as well as key quality assurance gui
'/>"/>

SOURCE College of American Pathologists
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Yakima Health Care Leader Tapped for Leadership Post at National Association
2. Tennessee Faith Leaders Call on Reps. Gordon & Blackburn to Co-sponsor Legislation to Protect Kids from Tobacco
3. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
4. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
5. Patent Reform Legislation Threatens Americas Leadership in Medical Technology Innovation
6. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
7. Hooper Holmes Launches Health & Wellness Division at 2007 Disease Management Leadership Forum and Integrated Care Summit
8. CEO Addresses Tennessee Business Leaders About Developing Pandemic and Business Continuity Plans
9. Blue Care Network of Michigan Earns National Leadership Award for Chronic Disease Management
10. Schooner Healthcare Services, LLC Announces New Leadership Team
11. U.S. Reps. Oberstar and Walz Discuss DM&E Railroad Expansion With Rochester, Minn. Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...RSBURG, Fla., Nov. 21 Mayor Rick B...l are partnering with the American Lung Associatio...enza initiative to educate St. Petersburg and Tam...al vaccination to help protect themselves and thei...pport of the initiative, Mayor Baker, Council Chai...
(Date:11/21/2008)...la., Nov. 21 Unilens Vis...Exchange: UVI), which develops, licenses,manufac...enses, today reported,its operating results for t.... , Net sales, excluding royalty income, in...r, compared with $1,673,361 in the previous year f...
(Date:11/21/2008)...ll easier to take, has fewer side effects than ch... 21 (HealthDay News) -- The cancer-fighting pill I...ne treatment for lung cancer, researchers report. ...yond eight months, Iressa (gefitinib) causes fewer...or patients who did not do well on their first rou...
(Date:11/21/2008)..., Nov. 21 Keryx Biopharm... that on November 17, 2008, it received notice fro...the Company is no longer in compliance with Market...to have a minimum of $2,500,000 in stockholders, e...ities, or $500,000 of net income from continuing o...
Breaking Medicine News(10 mins):Health News:Mayor Rick Baker and the American Lung Association Encourage St. Petersburg Residents to Get Immunized Against Influenza 2Health News:Mayor Rick Baker and the American Lung Association Encourage St. Petersburg Residents to Get Immunized Against Influenza 3Health News:Unilens Vision Reports Record First Quarter Revenue, Earnings and Royalty Income 2Health News:Unilens Vision Reports Record First Quarter Revenue, Earnings and Royalty Income 3Health News:Unilens Vision Reports Record First Quarter Revenue, Earnings and Royalty Income 4Health News:Iressa as Good as Chemotherapy for Lung Cancer 2Health News:Iressa as Good as Chemotherapy for Lung Cancer 3Health News:Keryx Biopharmaceuticals Receives Nasdaq Notification 2Health News:Keryx Biopharmaceuticals Receives Nasdaq Notification 3
...ion (WHO) today released the first ever country-by... factors have on health, and it revealed that 13 m...year by making environments healthier. The report...monstrate that in every country, people's health c...
...rs in new University of Cincinnati (UC) childhood...r underlying vascular malformations. In a retros...al (brain) arterial aneurysms, Todd Abruzzo, MD, f...eurysm among all age groups appeared to occur spon...
... aspirin effectively treats patients with heart di...esistance is rare, less than 5 percent, at all dos...y millions of patients to prevent and treat corona...t coronary artery disease deaths are caused by pla...
...ve been dubbed as being preoccupied with the physi...h men and women change their gender roles when the...y of Florida study demonstrates that men are under...a number of different partners, and women are rega...
Other Medicine News:Health News:13 Million Die Worldwide Due to Unhealthy Environment: New WHO Report 2Health News:Different Causes for Childhood Brain Aneurysm was Revealed 2Health News:Men and Women Change Attitudes to Sex When in an Intimate Relationship 2Health News:Men and Women Change Attitudes to Sex When in an Intimate Relationship 3
(Date:11/12/2008)...12 A new study being,pu...ll help answer the,question, what causes Parkinson...n the medical research into,Parkinson,s disease is...ie,in the first place. Answering this question has...early identical types of brain cells that produce,...
(Date:11/12/2008)... and LOD, Israel, November 12 Surg..., NY indicated that,patient-specific CTA data can ...entor(TM), Simbionix US) with high face validity. ... improved the operative flow,increased patient sa...verall operative and fluoroscopy time and the amou...
(Date:11/12/2008)...en Label Study and New Data Suggesting Need for Im...08 Annual Meeting -, EXTON, Pa., Nov. 12 /PRNewsw... VPHM ) today announced the presentation of data ...n this study Cinryze(TM) C1 inhibitor,therapy succ...ioedema (HAE),attacks seen in the study through th...
(Date:11/12/2008)... The Miami Jewish Home and Hospital...inical Research today,announced that they are acti... Phase 3 clinical trial that is evaluating the saf...on as a treatment for mild-to-moderate,Alzheimer,s...zheimer,s Association, more than,5 million people ...
Breaking Medicine Technology:A Window Into Parkinson's Disease 2Vascular Surgeons Agree: Case Rehearsal Improves Outcomes 2ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 2ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 3ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 4ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 5ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 6Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 2Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimer's Disease 3Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ 276 1Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ 276 2Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ 276 3Study finds limiting work hours for surgical residents enhances training 1351 1Study finds limiting work hours for surgical residents enhances training 1351 2Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines Innovation and New Research 1346 1Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines Innovation and New Research 1346 2Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines Innovation and New Research 1346 3BioMed Realty Trust Declares Third Quarter 2007 Common Stock and Preferred Stock Dividends 603 1BioMed Realty Trust Declares Third Quarter 2007 Common Stock and Preferred Stock Dividends 603 2
...T, June 11, 2007 (MARKET WIRE via COMTEX News,Netw...arget=,"_blank" href="http://www.myriad.com/">www....athematical comparison of a,"Staggered Start" and ...th a "Natural History Staggered Start" clinical tr...on Conference held,June 9 - 12, 2007, in Washingto...
...INESS WIRE)--Jun 12, 2007 - Inspire,Pharmaceutical...ists and collaborators related to Inspire will pre...ean Academy of,Allergology and Clinical Immunology...weden and at the 30th European Cystic Fibrosis,Soc... in Belek,Turkey., The EAACI Congress includes tw...
Other Medicine Technology:Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 2Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 3Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 4Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification 5Inspire Announces Presentations at Two European Scientific,Conferences 2Inspire Announces Presentations at Two European Scientific,Conferences 3
An excellent preventative/thera-peutic device for wearing during sports or construction activity. Helps dampen vibration and shock often transmitted during periods of repetitive motion. Provides re
...controlling range of motion of the elbow., ,While...remity bracing solutions, in recent years an incre...custom and post-operative elbow stabilization brac...braces come in single hinge and dual hinge designs...
Premium Tennis Elbow Support is 2" wide with loop-lock contact closure and is foam-lined for comfort.
...Joint Technology" elbow brace has been designed by...h pain free range of motion. ,The SADER II Elbow/F...inician and patient with adjustable static and dyn... and Forearm Fractures, Post Surgical loss of Moti...
Medicine Products: